Pfizer halted development of its weight-loss pill, danuglipron, after liver injury concerns surfaced during trials, impacting its ambition ...

The deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...

Ugur Sahin, the chief executive of BioNTech, rejected the U.S.-backed proposal to temporarily lift some intellectual property rights for va...

Although the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which h...

The company had posted a net profit after taxes and minority interest of Rs 795.55 crore for the corresponding period previous fiscal.

Shares of Ranbaxy were trading lower in early trade on Wednesday, following reports that the company is still struggling to get approvals f...

Faced with losses once its blockbusters start losing patents, Big Pharma is now devising strategies to counter the impact.

Foreign drugmakers are poised to regain the supremacy they ceded during the 1970s, thanks to their strategy of gobbling up India’s leading ...

Acquisitions to help MNCs control nearly 50% of $9.5-billion domestic retail drug market: Analysts

Boehringer Ingelheim in talks with Cipla for supply of generic drugs to the $17-bn German coa for two drugs.

Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...

A legal battle between Pfizer and Sun Pharmaceutical has escalated.

Increased use of generic drugs helped the US healthcare system save billions of dollars over last decade. 6 mysteries about swine flu | Swi...

Pfizer, the world’s largest drugmaker, said third-quarter profit fell 77% on costs for ending sales of the diabetes treatment Exubera and c...

Indian generic pharma companies may now find it easier to challenge patents in the US. In another twist in the battle between innovators an...

Pfizer will likely slash staff and accelerate merger and licencing deals as the pressure on it to improve its financial performance intensi...

The stock markets were disappointed at GE Shipping’s proposed demerger of its offshore business falling through. The scrip closed 1.2% down...